Wiener Neustadt, Austria

Manfred Berger

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Wr. Neustadt, AT (2013)
  • Wiener Neustadt, AT (2013 - 2014)

Company Filing History:


Years Active: 2013-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Manfred Berger: Innovator in Pharmaceutical Composition

Introduction

Manfred Berger is a notable inventor based in Wiener Neustadt, Austria. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of vaccines and diagnostic methods. With a total of 3 patents, his work has had a considerable impact on medical science.

Latest Patents

Berger's latest patents include innovative compositions that comprise protective proteins and peptides. These inventions focus on methods for producing pharmaceutical compositions, especially vaccines, that can be used for immunization or treatment of various infections. His patents also cover methods for diagnosing infections and identifying ligands that bind to specific peptides, showcasing his expertise in the intersection of immunology and biotechnology.

Career Highlights

Throughout his career, Manfred Berger has worked with prominent companies in the biotechnology sector, including Intercell AG and Valneva Austria GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in vaccine development and therapeutic solutions.

Collaborations

Berger has collaborated with esteemed colleagues such as Eszter Nagy and Andreas Meinke. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the research initiatives they are involved in.

Conclusion

Manfred Berger's contributions to the field of pharmaceutical compositions and vaccines highlight his role as a key innovator in medical science. His patents and collaborations reflect a commitment to advancing healthcare solutions through innovative research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…